Observations placeholder
Galantamine Hydrobromide
Identifier
019079
Type of Spiritual Experience
Background
A description of the experience
Galantamine (Nivalin, Razadyne, Razadyne ER, Reminyl, Lycoremine) is used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments, in particular those of vascular origin. It is an alkaloid that is obtained synthetically or from the bulbs and flowers of Galanthus caucasicus (Caucasian snowdrop, Voronov's snowdrop), Galanthus woronowii (Amaryllidaceae) and related genera like Narcissus (daffodil), Leucojum aestivum (snowflake., The U.S. Food and Drug Administration (FDA) and international health authorities have published an alert of galantamine based on data from two studies during the treatment for mild cognitive impairment (MCI); higher mortality rates were seen in drug-treated patients On April 27, 2006, FDA approved labeling changes concerning all form of galantamine preparations (liquid, regular tablets, and extended release tablets) warning of the risk of bradycardia (slow resting heart rate), and sometimes atrioventricular block, especially in predisposed persons. At the same time, the risk of syncope (fainting) seems to be increased relative to placebo. "In randomized controlled trials, bradycardia was reported more frequently in galantamine-treated patients than in placebo-treated patients, but was rarely severe and rarely led to treatment discontinuation" These side effects have not been reported in Alzheimer's Disease related studies
On Dec, 18, 2015: 1,514 people reported to have side effects when taking Galantamine hydrobromide. Among them, 35 people (2.31%) have Hallucination.
Time on Galantamine hydrobromide when people have Hallucination :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Hallucination76.47%17.65%5.88%0.00%0.00%0.00%0.00%
On Dec, 21, 2015: 1,514 people reported to have side effects when taking Galantamine hydrobromide. Among them, 50 people (3.30%) have Death.
Time on Galantamine hydrobromide when people have Death :
< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ years Death18.18%27.27%0.00%54.55%0.00%0.00%0.00%